PLATFORMS & PROJECTS
DaSH Global are launching DAX research platforms in different cancers by collaborating with national advocacy groups.
The following DAX platforms have been launched:
DAX in Mesothelioma – in collaboration with Mesothelioma UK
DAX in Lung Cancer – in collaboration with Lung Cancer Nursing UK
DaSH are in discussions to launch new DAX research platforms in other cancers.
DaSH Global in collaboration with Mesothelioma UK have undertaken the Medical Outcomes Research & Evidence (MORE) study in Mesothelioma. This collected prospective cross-sectional data on Patient Reported Outcomes, Experience and clinical information from both patients and Mesothelioma Clinical Nurse Specialists
MOREin Mesothelioma recruited 503 patients between QI-III 2019. (20% of the prevalent population). Data is available and can be analysed via the Microsoft Dynamics MORE data platform